These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36246008)

  • 1. Atrophy Expansion Rates in Stargardt Disease Using Ultra-Widefield Fundus Autofluorescence.
    Heath Jeffery RC; Thompson JA; Lo J; Lamey TM; McLaren TL; McAllister IL; Mackey DA; Constable IJ; De Roach JN; Chen FK
    Ophthalmol Sci; 2021 Mar; 1(1):100005. PubMed ID: 36246008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.
    Strauss RW; Ho A; Muñoz B; Cideciyan AV; Sahel JA; Sunness JS; Birch DG; Bernstein PS; Michaelides M; Traboulsi EI; Zrenner E; Sadda S; Ervin AM; West S; Scholl HP;
    Ophthalmology; 2016 Apr; 123(4):817-28. PubMed ID: 26786511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CLASSIFYING ABCA4 MUTATION SEVERITY USING AGE-DEPENDENT ULTRA-WIDEFIELD FUNDUS AUTOFLUORESCENCE-DERIVED TOTAL LESION SIZE.
    Heath Jeffery RC; Thompson JA; Lamey TM; McLaren TL; McAllister IL; Constable IJ; Mackey DA; De Roach JN; Chen FK
    Retina; 2021 Dec; 41(12):2578-2588. PubMed ID: 34125082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9).
    Strauss RW; Muñoz B; Ho A; Jha A; Michaelides M; Cideciyan AV; Audo I; Birch DG; Hariri AH; Nittala MG; Sadda S; West S; Scholl HPN;
    JAMA Ophthalmol; 2017 Nov; 135(11):1232-1241. PubMed ID: 29049437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Influencing Retinal Pigment Epithelium-Atrophy Progression Rate in Stargardt Disease.
    Cicinelli MV; Rabiolo A; Brambati M; Viganò C; Bandello F; Battaglia Parodi M
    Transl Vis Sci Technol; 2020 Jun; 9(7):33. PubMed ID: 32832238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 5.
    Strauss RW; Muñoz B; Ho A; Jha A; Michaelides M; Mohand-Said S; Cideciyan AV; Birch D; Hariri AH; Nittala MG; Sadda S; Scholl HPN;
    JAMA Ophthalmol; 2017 Jul; 135(7):687-695. PubMed ID: 28542697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral Visual Fields in ABCA4 Stargardt Disease and Correlation With Disease Extent on Ultra-widefield Fundus Autofluorescence.
    Abalem MF; Otte B; Andrews C; Joltikov KA; Branham K; Fahim AT; Schlegel D; Qian CX; Heckenlively JR; Jayasundera T
    Am J Ophthalmol; 2017 Dec; 184():181-188. PubMed ID: 29038010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, Genotypic, and Imaging Characterization of the Spectrum of ABCA4 Retinopathies.
    Romano F; Lamanna F; Boon CJF; Siligato A; Kalra G; Agarwal A; Medori C; Bertelli M; Pellegrini M; Invernizzi A; Staurenghi G; Salvetti AP
    Ophthalmol Retina; 2024 May; 8(5):509-519. PubMed ID: 37924945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of Visual Acuity and Fundus Autofluorescence in Recent-Onset Stargardt Disease: ProgStar Study Report #4.
    Kong X; West SK; Strauss RW; Munoz B; Cideciyan AV; Michaelides M; Ho A; Ahmed M; Schönbach EM; Cheetham JK; Ervin AM; Scholl HPN;
    Ophthalmol Retina; 2017; 1(6):514-523. PubMed ID: 31047445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-Specific Lesion Growth Rates in Stargardt Disease.
    Heath Jeffery RC; Thompson JA; Lo J; Lamey TM; McLaren TL; McAllister IL; Constable IJ; De Roach JN; Chen FK
    Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of Late-Onset Stargardt Type 1 Disease: Characteristics, Genetics, and Progression.
    Li CHZ; Pas JAAH; Corradi Z; Hitti-Malin RJ; Hoogstede A; Runhart EH; Dhooge PPA; Collin RWJ; Cremers FPM; Hoyng CB
    Ophthalmology; 2024 Jan; 131(1):87-97. PubMed ID: 37598860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostication in Stargardt Disease Using Fundus Autofluorescence: Improving Patient Care.
    Daich Varela M; Laich Y; Hashem SA; Mahroo OA; Webster AR; Michaelides M
    Ophthalmology; 2023 Nov; 130(11):1182-1190. PubMed ID: 37331482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 24-Month Period (ProgStar Report No. 17).
    Strauss RW; Ho A; Jha A; Fujinami K; Michaelides M; Cideciyan AV; Audo I; Birch DG; Sadda S; Ip M; West S; Schönbach EM; Kong X; Scholl HPN;
    Am J Ophthalmol; 2023 Jun; 250():157-170. PubMed ID: 36764427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and genetic characteristics of late-onset Stargardt's disease.
    Westeneng-van Haaften SC; Boon CJ; Cremers FP; Hoefsloot LH; den Hollander AI; Hoyng CB
    Ophthalmology; 2012 Jun; 119(6):1199-210. PubMed ID: 22449572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Genotype and Phenotype Severity in ABCA4-Associated Retinopathy.
    Bianco L; Arrigo A; Antropoli A; Manitto MP; Martina E; Aragona E; Bandello F; Battaglia Parodi M
    JAMA Ophthalmol; 2023 Sep; 141(9):826-833. PubMed ID: 37498587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Green Versus Blue Fundus Autofluorescence in
    Müller PL; Pfau M; Mauschitz MM; Möller PT; Birtel J; Chang P; Gliem M; Schmitz-Valckenberg S; Fleckenstein M; Holz FG; Herrmann P
    Transl Vis Sci Technol; 2018 Sep; 7(5):13. PubMed ID: 30279998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of ultra-widefield fundus autofluorescence.
    Xu A; Chen C
    Int Ophthalmol; 2021 Feb; 41(2):727-741. PubMed ID: 33040254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Hydroxychloroquine Retinopathy Using Ultra-Widefield Fundus Autofluorescence: Peripheral Findings in the Retinopathy.
    Ahn SJ; Joung J; Lee BR
    Am J Ophthalmol; 2020 Jan; 209():35-44. PubMed ID: 31526798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral Retinal Involvement in Extensive Macular Atrophy with Pseudodrusen-Like Deposits.
    Battaglia Parodi M; Antropoli A; Bianco L; Arrigo A; Pili L; Saladino A; Bandello F
    Ophthalmol Retina; 2023 Oct; 7(10):910-917. PubMed ID: 37423485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Macular Atrophy Detected by Fundus Autofluorescence in Patients With Neovascular Age-Related Macular Degeneration After Long-Term Ranibizumab Treatment.
    Kuehlewein L; Dustin L; Sagong M; Hariri A; Mendes TS; Rofagha S; Bhisitkul RB; Sadda SR
    Ophthalmic Surg Lasers Imaging Retina; 2016 Mar; 47(3):224-31. PubMed ID: 26985795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.